Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidence.

چکیده

We review the role of levodopa (L-DOPA), a dopamine precursor used to treat Parkinson disease, as a candidate for retinal neuroprotection, focusing on retinal dopamine biology, mechanisms of action, and evidence from preclinical and clinical studies. Selected experimental and clinical studies…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط